A detailed history of Verity & Verity, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Verity & Verity, LLC holds 531,036 shares of PFE stock, worth $15.8 Million. This represents 1.7% of its overall portfolio holdings.

Number of Shares
531,036
Previous 552,121 3.82%
Holding current value
$15.8 Million
Previous $15.4 Million 3.82%
% of portfolio
1.7%
Previous 1.72%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 16, 2024

SELL
$25.26 - $29.6 $532,607 - $624,116
-21,085 Reduced 3.82%
531,036 $14.9 Million
Q2 2024

Aug 08, 2024

BUY
$25.26 - $29.6 $13.9 Million - $16.3 Million
552,121 New
552,121 $15.4 Million
Q1 2024

Sep 16, 2024

SELL
$25.89 - $29.73 $2 Million - $2.29 Million
-77,156 Reduced 13.97%
474,965 $13.2 Million
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $6.79 Million - $8.81 Million
-259,710 Reduced 58.35%
185,407 $5.34 Million
Q3 2023

Oct 19, 2023

BUY
$32.09 - $37.51 $1.26 Million - $1.47 Million
39,133 Added 9.64%
445,117 $14.8 Million
Q2 2023

Jul 10, 2023

BUY
$36.12 - $41.79 $1.41 Million - $1.63 Million
38,983 Added 10.62%
405,984 $14.9 Million
Q1 2023

May 02, 2024

BUY
$39.39 - $51.28 $14.5 Million - $18.8 Million
367,001 New
367,001 $15 Million
Q1 2023

Apr 03, 2023

BUY
$39.39 - $51.28 $662,776 - $862,837
16,826 Added 4.81%
367,001 $15 Million
Q4 2022

Jan 11, 2023

BUY
$41.75 - $54.5 $506,051 - $660,594
12,121 Added 3.59%
350,175 $0
Q3 2022

Oct 24, 2022

BUY
$43.76 - $53.42 $361,151 - $440,875
8,253 Added 2.5%
338,054 $14.8 Million
Q2 2022

Jun 30, 2022

BUY
$46.53 - $55.17 $94,967 - $112,601
2,041 Added 0.62%
329,801 $17.3 Million
Q1 2022

May 03, 2022

BUY
$45.75 - $56.69 $134,367 - $166,498
2,937 Added 0.9%
327,760 $17 Million
Q4 2021

Feb 01, 2022

SELL
$41.32 - $61.25 $32,808 - $48,632
-794 Reduced 0.24%
324,823 $19.2 Million
Q3 2021

Nov 04, 2021

BUY
$39.25 - $50.42 $241,819 - $310,637
6,161 Added 1.93%
325,617 $14.6 Million
Q2 2021

Sep 20, 2021

SELL
$35.91 - $40.68 $5,745 - $6,508
-160 Reduced 0.05%
319,456 $12.5 Million
Q1 2021

Jun 21, 2021

BUY
$33.49 - $37.77 $1.19 Million - $1.34 Million
35,491 Added 12.49%
319,616 $12.4 Million
Q4 2020

Jan 12, 2021

BUY
$33.47 - $42.56 $532,875 - $677,597
15,921 Added 5.94%
284,125 $10.7 Million
Q3 2020

Oct 06, 2020

BUY
$31.75 - $37.25 $5.09 Million - $5.97 Million
160,235 Added 148.41%
268,204 $9.86 Million
Q2 2020

Jul 14, 2020

BUY
$30.12 - $36.54 $265,056 - $321,552
8,800 Added 8.87%
107,969 $3.8 Million
Q1 2020

Apr 09, 2020

SELL
$27.03 - $38.62 $582,226 - $831,874
-21,540 Reduced 17.84%
99,169 $3.24 Million
Q4 2019

Jan 08, 2020

BUY
$32.92 - $37.36 $13,332 - $15,130
405 Added 0.34%
120,709 $4.73 Million
Q3 2019

Oct 11, 2019

SELL
$32.49 - $42.13 $606,588 - $786,567
-18,670 Reduced 13.43%
120,304 $4.29 Million
Q2 2019

Jul 17, 2019

BUY
$36.98 - $41.52 $266,699 - $299,442
7,212 Added 5.47%
138,974 $6.02 Million
Q1 2019

Apr 29, 2019

SELL
$37.5 - $41.2 $4.63 Million - $5.08 Million
-123,398 Reduced 48.36%
131,762 $5.6 Million
Q4 2018

Jan 16, 2019

BUY
$38.47 - $43.86 $144,070 - $164,255
3,745 Added 1.49%
255,160 $11.1 Million
Q3 2018

Oct 16, 2018

BUY
$34.47 - $41.81 $884,638 - $1.07 Million
25,664 Added 11.37%
251,415 $11.1 Million
Q2 2018

Jul 20, 2018

SELL
$32.98 - $35.16 $823,906 - $878,367
-24,982 Reduced 9.96%
225,751 $8.01 Million
Q2 2018

Jul 20, 2018

BUY
$32.98 - $35.16 $823,906 - $878,367
24,982 Added 11.07%
250,733 $9.1 Million
Q1 2018

Apr 25, 2018

BUY
$31.91 - $37.02 $201,990 - $234,336
6,330 Added 2.88%
225,751 $8.01 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $281,446 - $298,623
8,462 Added 4.01%
219,421 $7.95 Million
Q3 2017

Oct 31, 2017

BUY
$31.0 - $34.15 $6.54 Million - $7.2 Million
210,959
210,959 $7.53 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Verity & Verity, LLC Portfolio

Follow Verity & Verity, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verity & Verity, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verity & Verity, LLC with notifications on news.